N,N-dimethyl-2-sulfanylbenzamide;o-mercapto-N,N-dimethylbenzamide;EINECS 244-094-3;2-Mercapto-N,N-dimethylbenzamide;N,N-Dimethyl-2-mercaptobenzamide;BenzaMide, 2-Mercapto-N,N-diMethyl-
Axitinib Impurity refers to chemical byproducts or synthetic intermediates associated with the manufacture of Axitinib, a tyrosine kinase inhibitor. These impurities are critical for process control and regulatory compliance in pharmaceutical production. The primary structure typically matches specific degradation pathways or side reactions during synthesis.
Store under inert atmosphere at controlled temperatures below -20°C to prevent degradation. Strictly adhere to safety data sheets regarding skin contact and inhalation risks. Not intended for direct clinical use; handling requires certified laboratory protocols.